38 research outputs found
A physician-scientist preceptorship in clinical and translational research enhances training and mentorship
Abstract Background Dual degree program MD/PhD candidates typically train extensively in basic science research and in clinical medicine, but often receive little formal experience or mentorship in clinical and translational research. Methods To address this educational and curricular gap, the University of Wisconsin Medical Scientist Training Program partnered with the University of Wisconsin Institute for Clinical and Translational Research to create a new physician-scientist preceptorship in clinical and translational research. This six-week apprentice-style learning experienceâguided by a physician-scientist faculty mentorâintegrates both clinical work and a translational research project, providing early exposure and hands-on experience with clinically oriented research and the integrated career of a physician-scientist. Five years following implementation, we retrospectively surveyed students and faculty members to determine the outcomes of this preceptorship. Results Over five years, 38 students and 36 faculty members participated in the physician-scientist preceptorship. Based on student self-assessments (n =â29, response rate 76%), the course enhanced competency in conducting translational research and understanding regulation of clinical research among other skills. Mentor assessments (n =â17, response rate 47%) supported the value of the preceptorship in these same areas. Based on work during the preceptorship, half of the students produced a peer-reviewed publication or a meeting abstract. At least eleven peer-reviewed manuscripts were generated. The preceptorship also provided a structure for physician-scientist mentorship in the studentsâ clinical specialty of choice. Conclusion The physician-scientist preceptorship provides a new curricular model to address the gap of clinical research training and provides for mentorship of physician-scientists during medical school. Future work will assess the long-term impact of this course on physician-scientist career trajectories
Hypoxia extends lifespan and neurological function in a mouse model of aging.
There is widespread interest in identifying interventions that extend healthy lifespan. Chronic continuous hypoxia delays the onset of replicative senescence in cultured cells and extends lifespan in yeast, nematodes, and fruit flies. Here, we asked whether chronic continuous hypoxia is beneficial in mammalian aging. We utilized the Ercc1 Î/- mouse model of accelerated aging given that these mice are born developmentally normal but exhibit anatomic, physiological, and biochemical features of aging across multiple organs. Importantly, they exhibit a shortened lifespan that is extended by dietary restriction, the most potent aging intervention across many organisms. We report that chronic continuous 11% oxygen commenced at 4 weeks of age extends lifespan by 50% and delays the onset of neurological debility in Ercc1 Î/- mice. Chronic continuous hypoxia did not impact food intake and did not significantly affect markers of DNA damage or senescence, suggesting that hypoxia did not simply alleviate the proximal effects of the Ercc1 mutation, but rather acted downstream via unknown mechanisms. To the best of our knowledge, this is the first study to demonstrate that "oxygen restriction" can extend lifespan in a mammalian model of aging
A Gly-Zipper Motif Mediates Homodimerization of the Transmembrane Domain of the Mitochondrial Kinase ADCK3
Interactions
between α-helices within the hydrophobic environment
of lipid bilayers are integral to the folding and function of transmembrane
proteins; however, the major forces that mediate these interactions
remain debated, and our ability to predict these interactions is still
largely untested. We recently demonstrated that the frequent transmembrane
association motif GAS<sub>right</sub>, the GxxxG-containing fold of
the glycophorin A dimer, is optimal for the formation of extended
networks of C뱉H hydrogen bonds, supporting the hypothesis
that these bonds are major contributors to association. We also found
that optimization of C뱉H hydrogen bonding and interhelical
packing is sufficient to computationally predict the structure of
known GAS<sub>right</sub> dimers at near atomic level. Here, we demonstrate
that this computational method can be used to characterize the structure
of a protein not previously known to dimerize, by predicting and validating
the transmembrane dimer of ADCK3, a mitochondrial kinase. ADCK3 is
involved in the biosynthesis of the redox active lipid, ubiquinone,
and human ADCK3 mutations cause a cerebellar ataxia associated with
ubiquinone deficiency, but the biochemical functions of ADCK3 remain
largely undefined. Our experimental analyses show that the transmembrane
helix of ADCK3 oligomerizes, with an interface based on an extended
Gly-zipper motif, as predicted by our models. The data provide strong
evidence for the hypothesis that optimization of C뱉H
hydrogen bonding is an important factor in the association of transmembrane
helices. This work also provides a structural foundation for investigating
the role of transmembrane association in regulating the biological
activity of ADCK3
Mitochondrial COQ9 is a lipid-binding protein that associates with COQ7 to enable coenzyme Q biosynthesis
Decreased plasma cartilage acidic protein 1 in COVIDâ19
Abstract Cartilage acidic proteinâ1 (CRTAC1) is produced by several cell types, including Type 2 alveolar epithelial (T2AE) cells that are targeted by SARSâCoV2. Plasma CRTAC1 is known based on proteomic surveys to be low in patients with severe COVIDâ19. Using an ELISA, we found that patients treated for COVIDâ19 in an ICU almost uniformly had plasma concentrations of CRTAC1 below those of healthy controls. Magnitude of decrease in CRTAC1 distinguished COVIDâ19 from other causes of acute respiratory decompensation and correlated with established metrics of COVIDâ19 severity. CRTAC1 concentrations below those of controls were found in some patients a year after hospitalization with COVIDâ19, long COVID after less severe COVIDâ19, or chronic obstructive pulmonary disease. Decreases in CRTAC1 in severe COVIDâ19 correlated (râ=â0.37, pâ=â0.0001) with decreases in CFP (properdin), which interacts with CRTAC1. Thus, decreases of CRTAC1 associated with severe COVIDâ19 may result from loss of production by T2AE cells or coâdepletion with CFP. Determination of significance of and reasons behind decreased CRTAC1 concentration in a subset of patients with long COVID will require analysis of roles of preexisting lung disease, impact of prior acute COVIDâ19, age, and other confounding variables in a larger number of patients
An Isoprene Lipid-Binding Protein Promotes Eukaryotic Coenzyme Q Biosynthesis
The biosynthesis of coenzyme Q presents a paradigm for how cells surmount hydrophobic barriers in lipid biology. In eukaryotes, CoQ precursors-among nature's most hydrophobic molecules-must somehow be presented to a series of enzymes peripherally associated with the mitochondrial inner membrane. Here, we reveal that this process relies on custom lipid-binding properties of COQ9. We show that COQ9 repurposes the bacterial TetR fold to bind aromatic isoprenes with high specificity, including CoQ intermediates that likely reside entirely within the bilayer. We reveal a process by which COQ9 associates with cardiolipin-rich membranes and warps the membrane surface to access this cargo. Finally, we identify a molecular interface between COQ9 and the hydroxylase COQ7, motivating a model whereby COQ9 presents intermediates directly to CoQ enzymes. Overall, our results provide a mechanism for how a lipid-binding protein might access, select, and deliver specific cargo from a membrane to promote biosynthesis